FORM DEF 14A

Company

IGC Pharma, Inc.

Filed

December 8, 2020

Period of Report

January 11, 2021

Accession Number

0001185185-20-001724

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →